Delaying neutrophil uptake may preserve vesicle-mediated complement inhibition
After suppression of prostaglandin E2 receptor type 2 (EP2), delaying neutrophil uptake may improve muscle, heart and lung recovery by preserving protective vesicles. Failure of neutrophil-specific CD55 loss to abolish the added benefit would reject the proposed dependence on this protein.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Immune response
Efferocytosis
The engulfment and clearance of apoptotic cells by phagocytes
Where this hypothesis actsNeutrophil clearance during recovery under EP2 blockade, before protective vesicles have formed
Hypotheses on this target 8
Inhibition5
Activation2
Function preservation
Clearance restoration1
Immunosuppression
Feedback restoration
Rhythm restoration

What is proposed
Inhibition
Selectively delay neutrophil engulfment
With whatNot stated in the record
HowSelectively alter engulfment of whole neutrophils while preserving vesicle formation and clearance; the specific intervention is not stated
Possible result
Possible additional improvement in muscle, heart and lung recovery through sustained protective vesicle production
From the recordПоэтому избирательная задержка их поглощения должна усиливать многосистемную пользу подавления EP2.

Receptor or channel
EP2 receptor
A receptor whose activity can be suppressed
Where this hypothesis actsDuring recovery from injury, alongside selective inhibition of neutrophil engulfment
Hypotheses on this target 5
Lower level
Higher level
Blockade5
Agonism
Desensitisation
Function restoration
Function preservation

What is proposed
Blockade
Suppress EP2 receptor activity
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible multisystem recovery benefits enhanced by delaying neutrophil engulfment
From the recordПосле подавления рецептора простагландина E2 типа 2 (EP2)

Immune response
Complement cascade
An enzymatic cascade involved in immune responses
Where this hypothesis actsExtracellularly during inflammation resolution after EP2 suppression
Hypotheses on this target 1
Inhibition1
Activation
Function preservation
Clearance restoration
Immunosuppression
Feedback restoration
Rhythm restoration

What is proposed
Inhibition
Sustain extracellular inhibition of the complement cascade
With whatProtein or peptide as the agent
HowPreserve neutrophil production of CD55-positive extracellular vesicles by delaying engulfment; administer purified vesicles in the rescue experiment
Possible result
Possible shortening of the inflammation-resolution period SPV_3 and improved multisystem recovery
From the recordОбщее причинное звено для потенциальной «серебряной пули» здесь представляет сохранение внеклеточного ингибирования комплемента.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Recovery from damage might depend on how long certain immune cells remain available to make protective material. The unexpected move is to propose that delaying their removal could improve recovery across muscle, heart and lungs, even though the preceding question considered restored removal a possible source of benefit. This is a mechanism generated by the pipeline, not a measured result.
- EP2 suppression is proposed to change the environment around macrophages.
- That altered environment is proposed to let retained neutrophils finish making CD55-bearing vesicles.
- Delayed engulfment is proposed to keep neutrophils producing protection instead of having that production cut short by early removal.
- The released vesicles are proposed to sustain inhibition of complement.
- Reduced complement activity is proposed to shorten the time inflammation takes to resolve.
- This protection is proposed to improve recovery in muscle, heart and lungs.
A repair crew may still be making protective covers when a cleanup team arrives to take it away. Leaving the crew in place longer helps only if it finishes useful covers during that extra time.
Where the picture breaks: Retained immune cells can also cause damage, and removing the cells is different from removing the packages they release. The picture does not establish that EP2 suppression changes production or that the packages protect several organs.
- Master questionstep 01 of 04
Processes involved in ageing may reinforce one another, so changing a shared cause could benefit several body systems at once.
Rests on: The goal seeks a shared cause whose alteration could produce broad benefits for ageing.
AssumptionThe search assumes that a shared causal link can be altered to benefit several systems. The supplied material does not establish such a link for ageing as a whole.
- Goal pillarstep 02 of 04
Recovery should resist becoming stuck in a damaged state.
Rests on: The broad search for benefits across systems is narrowed to the persistence of recovery.
AssumptionThe stage takes resistance to a persistent damaged state as a useful focus for the search. The preceding goal does not explain why this property would provide a shared causal link.
- Gap questionstep 03 of 04
Benefits across several systems might survive EP2 suppression even when restored neutrophil removal is selectively prevented. Such a result is posed as a possible challenge to removal as the shared cause of recovery.
Rests on: The preceding focus on lasting recovery is narrowed to EP2 suppression and the removal of neutrophils.
LeapThe preceding stage supplies neither the choice of EP2 nor an established connection between EP2 suppression, restored neutrophil removal and benefits across systems. The supplied sources do not establish that connection. Preventing removal of whole cells would also leave removal of their released products as a competing explanation.
- Hypothesisstep 04 of 04
Neutrophils retained after EP2 suppression are proposed to finish producing extracellular vesicles, small membrane-enclosed packages released by cells, carrying CD55. These packages would restrain complement, a chain of immune protein reactions that can contribute to damage. An altered environment around macrophages, immune cells that engulf cells and other material, is proposed to permit this production; early engulfment of neutrophils would interrupt it.S5
Rests on: The preceding question makes neutrophil removal the point of comparison. The hypothesis supplies a reason delayed removal could help: retained cells would continue making protective packages. The screened Cell study from 2025 supports the narrower idea that persistent neutrophil-derived vesicles can sustain complement deactivation in mouse pneumonia; it does not establish EP2 involvement, delayed removal of whole neutrophils or benefits across several systems.
Supported by literature
What is carried, and what is not. The Cell study from 2025 supports a narrow part of the mechanism: persistence of neutrophil-derived vesicles sustained complement deactivation in a mouse pneumonia model, not through demonstrated retention of whole neutrophils after EP2 suppression. The Clinical Interventions in Aging study from 2025 identifies CD55 as a complement-regulating protein but does not establish the proposed protective route; no supplied source establishes the sequence from EP2 suppression to lasting recovery across muscle, heart and lungs.
Where the reasoning is carried by something unstated · 3
- Master question. The search assumes that a shared causal link can be altered to benefit several systems. The supplied material does not establish such a link for ageing as a whole.
- Goal pillar. The stage takes resistance to a persistent damaged state as a useful focus for the search. The preceding goal does not explain why this property would provide a shared causal link.
- Gap question. The preceding stage supplies neither the choice of EP2 nor an established connection between EP2 suppression, restored neutrophil removal and benefits across systems. The supplied sources do not establish that connection. Preventing removal of whole cells would also leave removal of their released products as a competing explanation. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Changing engulfment of whole neutrophils could also change production or removal of their vesicles. Any recovery difference could then be credited to keeping cells alive and available when it actually reflects altered handling of released material. What closes it: The work must separately establish the change in whole-cell engulfment, vesicle production and vesicle removal. Confirmed EP2 suppression and comparable initial damage are also required, as specified in the prediction.
- Loss of the extra benefit after removing CD55, followed by its return after vesicle delivery, could be treated as proof of complement inhibition even if vesicle abundance or other contents account for the effect. What closes it: Complement activity must be measured alongside recovery and vesicle abundance. A comparison with otherwise comparable vesicles lacking functional CD55 is needed to attribute the returned benefit specifically to CD55-dependent complement inhibition; that comparison is not specified in the supplied test.
- Early improvement in one organ could be read as recovery across systems while retained or displaced neutrophils contribute to later damage elsewhere. What closes it: Muscle, heart and lung function must be assessed separately over time, with the observation period and criteria for sustained benefit fixed before results are examined. Neutrophil location must also be tracked to distinguish recovery from redistribution of damage.
What would make this wrong. With EP2 suppression verified, initial damage comparable, whole-neutrophil engulfment selectively delayed and vesicle production and removal preserved, failure of delayed engulfment to add recovery benefit would contradict the central prediction. If an added benefit remained after verified removal of CD55 from neutrophils and loss of the proposed vesicle-mediated complement inhibition, it would contradict the claimed protective route even if another explanation still accounted for recovery.
What it would change. If the predicted loss and return of benefit held and were tied to complement inhibition, preserving protective output from retained immune cells would become a candidate shared cause of recovery. The search for a broadly effective ageing intervention would then have to distinguish removal of harmful material from premature removal of cells still making protection. Even that result would not establish longer life or durable benefits in ageing humans: the proposed test supplies no species or follow-up duration, and the directly relevant screened evidence concerns mouse pneumonia.
Sources read · 5
EP4 and EP2 receptor activation of protein kinase A by prostaglandin E2 impairs macrophage phagocytosis of Clostridium sordellii. · American journal of reproductive immunology (New York, N.Y. : 1989) · 2014
“Figure 2 EP2 and EP4 receptors mediate PGE 2 -induced intracellular cAMP increase and phagocytosis inhibition in THP-1 cells”
Does not settle: Источник не устанавливает влияние подавления EP2 на поглощение нейтрофилов, образование внеклеточных везикул с CD55, ингибирование комплемента, системную пользу или период разрешения воспаления SPV_3.
PGE2 inhibits neutrophil phagocytosis through the EP2R-cAMP-PTEN pathway. · Immunity, inflammation and disease · 2022
“This study showed that PGE2 inhibited PMN phagocytosis of Escherichia Coli ( E. coli ) via the E‐series of prostaglandin receptors type 2 (EP2R)–cAMP–phosphatase and tensin homolog (PTEN) pathway.”
Does not settle: It does not examine macrophage uptake of neutrophils, extracellular vesicles, CD55, complement inhibition, inflammation-resolution time, or the effects of EP2 suppression.
E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae. · Prostaglandins & other lipid mediators · 2012
“In conclusion, these studies reinforce and refine the emerging paradigm that PGE 2 can impair innate immune function during severe infection and suggest that targeting specific receptors could help prevent or treat pneumococcal pneumonia.”
Does not settle: This source does not establish neutrophil uptake or its delay, neutrophil extracellular vesicles, CD55, complement inhibition, macrophage-mediated vesicle formation, multisystem benefit of EP2 suppression, or the SPV_3 inflammation-resolution period.
Neutrophil-derived vesicles control complement activation to facilitate inflammation resolution. · Cell · 2025
“Thus, do not eat me signals on LAND-Vs contributed to their prolonged residency in the lungs, ensuring sustained complement deactivation.”
Does not settle: This source does not test EP2 inhibition, altered macrophage environments, delayed uptake of neutrophils themselves, multisystem benefit, or SPV_3. Its in vivo evidence is from a mouse pneumonia model and concerns clearance of neutrophil-derived vesicles.
Association of Decay Accelerating Factor (CD55) Positive Extracellular Vesicles with Advanced Age and Blood Glucose Levels in Elderly Individuals. · Clinical interventions in aging · 2025
“CD55 is a complement regulatory protein that has been linked to the progression of diabetes.”
Does not settle: This source does not establish that neutrophils produce CD55-positive vesicles, that their uptake is delayed, or any role for EP2 suppression, macrophages, complement-cascade inhibition by those vesicles, multisystem benefit, or SPV_3.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Does suppressing a cell signal still benefit several body systems when improved removal of worn-out immune cells is blocked?
Original wording · exactly as the pipeline generated it
Сохранится ли многосистемная польза подавления EP2, если избирательно воспрепятствовать восстановлению удаления нейтрофилов, и опровергнет ли такой результат очистку как общее причинное звено?
What this question is asking
The question asks whether improved removal of worn-out neutrophils, a type of immune cell, is necessary for benefits across several body systems. The intervention suppresses signaling through E prostanoid receptor subtype 2 (EP2) in tissue-resident macrophages, immune cells that live in tissues and remove cellular material. The comparison is between suppression that allows neutrophil removal to improve and the same suppression with that improvement selectively prevented. The question assumes that suppression improves both removal and several aspects of health in aged mice, while treating removal as a possible shared cause of those benefits. It also asks whether benefits persisting when improved removal is blocked would disprove that proposed causal explanation.
- E prostanoid receptor subtype 2 (EP2)
- A cell receptor through which prostaglandin E2 sends signals. The question concerns reducing its signaling in tissue-resident macrophages; the supplied sources report different consequences of this signaling in different settings.
- Prostaglandin E2
- A signaling molecule that acts through receptors including EP2. In the supplied sources, its signaling is linked to increased removal of dying cells, impaired bacterial killing, and protection against scarring, so its effects cannot be reduced to a single beneficial or harmful role.
- Neutrophils
- A type of immune cell. The question concerns removal of worn-out neutrophils, rather than their production or every function they perform.
- Senescent neutrophils
- The aged or worn-out neutrophils named in S1's title. The supplied material does not specify how that state was identified or whether it matches the dying-cell states studied in the other sources.
- Tissue-resident macrophages
- Immune cells that reside in tissues and can ingest cells and other material. They are the cells whose EP2 signaling was reduced in S1.
- Clearance
- Removal of cells or other material from a tissue. Here, the proposed causal step is improved removal of neutrophils; reduced accumulation alone would not specify how that reduction occurred.
- Programmed cell death
- An organized process through which cells die. The dying cells ingested in S6 should not automatically be treated as equivalent to every neutrophil described as senescent in S1.
- Mitochondrial fitness
- The functional condition of mitochondria, structures within cells involved in supplying usable energy. S1 reports preservation of this condition but the supplied quotation does not specify its measurement.
- Inflammation
- A tissue and immune response to injury or threats. Body-wide inflammation is one of S1's reported outcomes, while the question asks whether improved cell removal explains its reduction.
- Cognitive decline and frailty
- Cognitive decline means worsening abilities such as memory and thinking; frailty means increased vulnerability associated with reduced physical reserves. Both are outcomes named in S1, but their measurement criteria are not supplied.
- Hydrogen peroxide
- A reactive chemical involved in the bacterial-killing mechanism described in S5. That source links reduced production of it to impaired bacterial killing.
- Scarring
- Formation of fibrous tissue, also called fibrosis. S8 concerns a possible loss of protection against this process in the uterine lining.
- Selective prevention
- The question's assumed ability to stop improvement in neutrophil removal while keeping EP2 suppression effective and avoiding other changes that could explain the outcomes. The supplied sources do not establish that this separation was achieved.
- Necessary and sufficient causes
- A necessary step must occur for a particular benefit to occur under the stated conditions. A sufficient step can produce that benefit on its own; showing necessity does not establish sufficiency.
Suppressing EP2 improves neutrophil clearance and macrophage condition in aged mice and produces benefits across several body systems, with clearance proposed as their common causal link.
Neutrophils are immune cells, and tissue-resident macrophages are cells that can remove them as they become worn out. The assumption is that reducing signaling through a receptor on these macrophages improves their condition and removal work, alongside benefits elsewhere in the body. If established, that connection would provide the starting point for asking whether improved removal is required for those benefits.
S1 directly reports that reducing macrophage EP2 signaling in aged mice preserved mitochondrial fitness and prevented several adverse outcomes. Its title identifies restored clearance of senescent neutrophils as the subject, but the supplied abstract quotation does not detail that clearance result or establish its necessity for the broader benefits. S6 reports increased uptake of dying cells following EP2 activation in another setting, so a general claim that less EP2 signaling necessarily improves clearance is not supported. None of the supplied passages establishes clearance as the necessary common cause.S1S6
The same question asked without the part nothing read establishes:
- In aged mice, do the benefits of reducing EP2 signaling persist when improved neutrophil removal is selectively prevented?
- Which benefits of reducing EP2 signaling in aged mice require improved neutrophil removal?
- Benefits persist across systems If improved neutrophil removal were genuinely prevented while receptor suppression remained effective, persistent benefits would mean that this improvement was not necessary for those measured benefits under those conditions. That would challenge clearance restoration as their required common cause, while leaving possible contributions from existing clearance or other settings unresolved.
- Benefits disappear across systems Under the question's assumption of selective interference, losing the benefits would support a requirement for improved neutrophil removal. It would not by itself establish that removal is the sole cause or that improving removal alone is sufficient to produce those benefits.
- Some benefits persist and others disappear Under the same selectivity assumption, the outcomes would differ in their dependence on improved neutrophil removal. Clearance restoration could then explain some benefits without serving as a necessary common link for every measured system.
The proposed chain runs from reduced receptor signaling to improved removal of worn-out immune cells, then to less inflammation and better function across several body systems. If improved removal is necessary, blocking that improvement would interrupt the chain despite continued receptor suppression. If benefits persist, the proposed explanation would need to distinguish benefits that require improved removal from benefits that do not. Mistaking an accompanying change for a necessary cause would misidentify why the intervention works; assuming that receptor suppression always helps would also overlook the opposing effects reported in other biological settings.
Подавление EP2 улучшает очистку и состояние макрофагов у мышей, RL-1; необходимость очистки для общего устойчивого эффекта отдельно не установлена.
Воспаление и функции возвращаются в заданные диапазоны за дни или недели; повторные нагрузки сохраняют восстановление нескольких систем месяцами.
Требуется разорвать предполагаемую причинную цепь и проверить, исчезает ли многосистемная польза при сохранённом воздействии на EP2.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
После подавления рецептора простагландина E2 типа 2 (EP2) главным источником устойчивой пользы становится сохранение нейтрофилов, которые образуют защитные внеклеточные везикулы с белком CD55. Предполагается, что изменённая среда макрофагов позволяет этим нейтрофилам завершить образование везикул, подавляющих ферментативный каскад комплемента. Ускоренное поглощение нейтрофилов преждевременно обрывает эту защиту. Поэтому избирательная задержка их поглощения должна усиливать многосистемную пользу подавления EP2. Общее причинное звено для потенциальной «серебряной пули» здесь представляет сохранение внеклеточного ингибирования комплемента. Оно должно сокращать период разрешения воспаления SPV_3.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При подтверждённом подавлении EP2 и одинаковом исходном повреждении блокада поглощения нейтрофилов дополнительно улучшает восстановление мышцы, сердца и лёгких. Этот дополнительный выигрыш исчезает при нейтрофил-специфическом выключении CD55 и возвращается после введения очищенных CD55-положительных везикул. Напротив, независимое ускорение удаления нейтрофилов при сохранённой блокаде EP2 ухудшает восстановление, если происходит до образования защитных везикул. Простое сохранение пользы при блокаде поглощения для подтверждения этой гипотезы недостаточно.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies conditional improvements and worsening of recovery, plus loss and restoration of the additional benefit under specified interventions. These qualitative outcomes are measurable. No rival prediction was supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Выделение таких везикул, оценка CD55 и условное выключение этого белка в нейтрофилах уже применялись. Главная экспериментальная трудность состоит в избирательном изменении поглощения целых нейтрофилов при сохранении образования и удаления их везикул.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При подтверждённом подавлении EP2 и одинаковом исходном повреждении блокада поглощения нейтрофилов дополнительно улучшает восстановление мышцы, сердца и лёгких. Этот дополнительный выигрыш исчезает при нейтрофил-специфическом выключении CD55 и возвращается после введения очищенных CD55-положительных везикул. Напротив, независимое ускорение удаления нейтрофилов при сохранённой блокаде EP2 ухудшает восстановление, если происходит до образования защитных везикул. Простое сохранение пользы при блокаде поглощения для подтверждения этой гипотезы недостаточно.
- What would separate them
Vesicle removal may limit damage from elastase shielded against its natural inhibitor predicts: При блокаде поглощения целых нейтрофилов эффект подавления EP2 сохраняется только при снижении количества везикул с активной эластазой. Возврат очищенной фракции таких везикул устраняет пользу; равное количество везикул с инактивированной эластазой этого не делает. При одинаковой активности против свободной эластазы малый ингибитор подавляет везикулярную протеазу и восстанавливает функции эффективнее крупного ингибитора. После отделения эластазы от поверхности размерная зависимость исчезает.
- What would separate them
Suppressing a prostaglandin receptor may curb ferroptosis through itaconate predicts: При подавлении EP2 и блокаде поглощения нейтрофилов функции улучшаются на фоне сопоставимых количества нейтрофилов, активности комплемента и внеклеточной эластазы. Одновременно снижаются окисленные фосфолипиды и гибель паренхиматозных клеток. Макрофаг-специфическое выключение фермента синтеза итаконата ACOD1 устраняет этот выигрыш; прямое подавление ферроптоза в клетках-мишенях восстанавливает его при продолжающейся блокаде поглощения. Отсутствие увеличения потока природного итаконата после подавления EP2 опровергает предложенную связь.
- What would separate them
Shared lipid synthesis in neutrophils and platelets may limit tissue damage predicts: Польза подавления EP2 сохраняется при блокаде поглощения нейтрофилов и сопровождается усилением образования липоксинов из изотопно меченного нейтрофильного предшественника. Тромбоцит-специфическое выключение 12-липоксигеназы устраняет этот эффект при сохранённых количестве нейтрофилов, активности CD55 на везикулах и потоке итаконата. Введение соответствующего продукта синтеза восстанавливает функции. Отсутствие зависимости от тромбоцитарного фермента при подтверждённом его выключении опровергает гипотезу.
- What would separate them
Neutrophil movement may shift damage between organs and mimic lasting recovery predicts: После подавления EP2 на фоне блокады поглощения меченые нейтрофилы исчезают из исходной ткани, но сохраняются в крови и обнаруживаются в удалённых органах. Раннее улучшение мышцы сопровождается отсроченным ухудшением лёгочной или сердечной функции после повторной обычной нагрузки. За заранее заданный период наблюдения согласованного функционального выигрыша трёх систем нет. Подтверждённое улучшение всех трёх систем на протяжении месяцев при отсутствии переноса клеточной нагрузки опровергает эту гипотезу.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
В экспериментальной работе нейтрофильные везикулы сохранялись благодаря защите от поглощения, а их CD55 подавлял комплемент и повреждение лёгких. Это создаёт проверяемый конфликт между удалением нейтрофильного материала и сохранением его защитной функции. [Исследование нейтрофильных везикул](https://pmc.ncbi.nlm.nih.gov/articles/PMC11934499/).
Геронтология врождённого иммунитета; учебная глава «Разрешение воспаления и эффероцитоз». Пересмотра потребует причинная модель, согласно которой ускоренное удаление стареющих нейтрофилов обеспечивает многосистемное действие подавления EP2. Гипотеза приписывает этому удалению противоположный знак в поздней фазе восстановления.
Избирательное торможение удаления нейтрофилов усиливает восстановление трёх систем после подавления EP2, тогда как восстановление их поглощения обращает этот выигрыш; обе зависимости определяются CD55 на везикулах.
Защитная функция нейтрофильных везикул уже описана и сама по себе еретической не является. Радикальное утверждение здесь состоит в том, что ускоренный эффероцитоз противодействует общему эффекту подавления EP2, а его блокада усиливает этот эффект. В просмотренных источниках такого утверждения не найдено; отсутствие его во всей литературе не установлено, поэтому статус HERETICAL остаётся предварительным.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.